One survivor shares how the support of the Cancer Institute at St. Francis and oncology nurse Rose Francucci helped her embrace her cancer journey with positivity.
When considering a stem cell transplantation, patients with cancer must be willing to take a chance.
“Only you have the power to make your life better,” says a myeloma survivor on living for the moment after a cancer diagnosis.
Being a parent affects EVERY decision in my life, even the ones regarding my cancer care.
The Skin Care Foundation emphasizes that skin cancer is highly treatable and can even be prevented.
Patients with newly diagnosed glioblastoma are now being accepted at two institutions to enter a phase 2 study to assess the efficacy of the SurVaxM vaccine in combination with standard chemotherapy.
A Lynch syndrome diagnosis shook my world. Here is what I wish I was told from the get-go.
An expert discusses the evolving treatments for renal cell carcinoma (RCC) over the last decade, as well as the future role of immunotherapies for patients with RCC.
Finalist essay for CURE’s 2011 Extraordinary Healer Award contest.
Genomic testing of gastrointestinal tumors can be essential to proper treatment.
Patients should research both the surgeon and the technique when deciding on treatment.
“Julie Pope came into my life as quickly as rectal cancer did,” wrote Anne Heimel in her nomination essay for CURE®’s 2019 Extraordinary Healer® Award. “Julie is also a champion in my personal life. She has done so many things that are not part of her job description.”
Nominee for CURE®’s 2019 Extraordinary Healer® award, oncology nurse Megan Roy’s insight is valued and trusted by both patients and her team, making care processes smooth no matter whether she worked directly with patients or not.
This article outlines three areas where LGBTQ patients and their caregivers may face challenges and how the Comprehensive Cancer Control Programs (CCCP) can address these needs. Written by Dr. Amari Pearson- Fields, the former Comprehensive Cancer Program Director for Washington DC.
Cutting-edge medical information and first-person accounts empower patients to evaluate immunotherapy as a treatment option, one organization attests.
Carolyn Presley discusses the implications of screening on diagnosis and treatment of lung cancer.
Kathryn Burn, head of Partnerships and Research at Smart Patients, discusses her organization's role in the National Cancer Moonshot Initiative.
Two decades ago, a patient with HER2-positive breast cancer had a single targeted drug option. Now a plethora of new and emerging treatments fill the landscape.
Joshua Bauml, M.D., assistant professor, Perelman School of Medicine, University of Pennsylvania, discusses the potential of therapeutic vaccine in patients who have head and neck cancer.
After beating stomach cancer, a grandmother transformed herself into a competitive amateur athlete to stay active and healthy.
CURE chooses the winning essay for it 2009 Extraordinary Healer Award for Oncology Nursing.
A certain group of patients may not be candidates for common therapies, explained Bijal D. Shah, M.D.
Even the smallest of realizations can feel like a miracle.
Mantle cell lymphoma remains incurable, despite researchers’ best efforts. However, new treatment options show promise in the relapsed/refractory setting and may improve patient outcomes if moved to the front-line, according to Dr. Reem Karmali.
Exercise and nutrition intervention for patients with cancer could help with symptoms from treatment.